ARCHIVES

Cancer Act Renewals Marked By Disputes Over NCI Authorities

This article is from The Cancer Letter archive.

Vol. 16 No. 38 | October 5, 1990

Download PDF Visit The Full Archive

Related Articles

Two Phase III Afatinib Trials Demonstrate Prolonged Survival

May 30, 2014

Poverty Play Key Role In Excess Cancer Deaths Among Minorities, President’s Cancer Panel Hears

July 26, 1991

Klausner Reaffirms NCI’s “No. 1 Priority” Is Funding investigator-Initiated Research

September 13, 1996

Nexavar Improves PFS In Phase III Trial

January 25, 2013

AACR Meeting: Celebrex Studies Show Benign Polyp Reduction, Point To Challenges In Biomarker Validation.

April 14, 2006

GSK’s Votrient Approved For Advanced Kidney Cancer

October 30, 2009